In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn

Leif K Nielsen, Trine H Green, Inger Sandlie, Terje E Michaelsen, Morten Hanefeld Dziegiel

7 Citationer (Scopus)

Abstract

A specific treatment for ongoing hemolytic disease of the fetus and newborn (HDFN) due to anti-D would be very attractive. One approach could be administration to the mother of nonhemolytic anti-D, which by crossing the placenta can block the binding of hemolytic maternal anti-D.
OriginalsprogEngelsk
TidsskriftTransfusion
Vol/bind48
Udgave nummer1
Sider (fra-til)12-9
Antal sider8
ISSN0041-1132
DOI
StatusUdgivet - 1 jan. 2008

Fingeraftryk

Dyk ned i forskningsemnerne om 'In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn'. Sammen danner de et unikt fingeraftryk.

Citationsformater